Daytime hypoglycemic episodes during the use of an advanced hybrid closed loop system.

Advanced hybrid closed loop system Daytime hypoglycemia Hypoglycemia Nighttime hypoglycemia Type 1 diabetes

Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 11 09 2023
revised: 30 10 2023
accepted: 10 11 2023
pubmed: 14 11 2023
medline: 14 11 2023
entrez: 13 11 2023
Statut: ppublish

Résumé

The use of advanced hybrid closed loop systems is spreading due to the beneficial effects on glycometabolic control obtained in patients with type 1 diabetes. However, hypoglycemic episodes can be sometimes a matter of concern. We aim to compare the hypoglycemic risk of an advanced hybrid closed loop system and a predictive low glucose suspend sensor augmented pump. In this retrospective three months observational study, we included 30 patients using Medtronic Minimed™ 780G advanced hybrid closed loop system and 30 patients using a Medtronic Minimed™ predictive low glucose suspend sensor augmented pump. The advanced hybrid closed loop system reduced the time spent above 180 mg/dL threshold and increased the time in range as compared to the predictive low glucose suspend. No severe hypoglycemia occurred in both groups and no differences were observed in the percentage of time spent below 70 mg/dl and 54 mg/dl glucose threshold. Nevertheless, more hypoglycemic episodes were recorded during daytime, but not in nighttime, with the use of the advanced hybrid closed loop system. Our results confirmed the general improvement of glycemic outcomes obtained with the advanced hybrid closed loop system; however more hypoglycemic episodes during daytime were evident.

Identifiants

pubmed: 37956944
pii: S0168-8227(23)00774-X
doi: 10.1016/j.diabres.2023.111011
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111011

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Antonio Rossi (A)

Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.

Laura Montefusco (L)

Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.

Elia Reseghetti (E)

Dept. Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy.

Ida Fabrizia Pastore (IF)

Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.

Giada Rossi (G)

Dept. Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy.

Vera Usuelli (V)

Dept. Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy.

Cristian Loretelli (C)

Dept. Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy; International Center for T1D - Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Milan, Italy.

Denisa Boci (D)

Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.

Moufida Ben Nasr (M)

Dept. Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy; International Center for T1D - Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Milan, Italy.

Francesca D'Addio (F)

Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy; Dept. Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy; International Center for T1D - Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Milan, Italy.

Loredana Bucciarelli (L)

Endocrinology Unit, IRCCS MultiMedica Sesto San Giovanni, Milan, Italy.

Sabrina Argenti (S)

Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.

Paola Morpurgo (P)

Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.

Maria Elena Lunati (ME)

Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.

Paolo Fiorina (P)

Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy; Dept. Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy; International Center for T1D - Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Milan, Italy; Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States. Electronic address: paolo.fiorina@childrens.harvard.edu.

Classifications MeSH